Preliminary Announcement: a transnational call for proposals on Personalised Medicine to be open soon
The overall objectives of the ERA PerMed call are (i) to support translational research projects in the field of Personalised Medicine; (ii) to encourage interdisciplinary collaboration between academia (research teams from universities, higher education institutions, public research performing institutions), clinical/public health research (research teams from hospital/ public health institutions, healthcare settings and other healthcare organisations) and private partners e.g. SMEs (small and medium-size enterprises).
This call for proposals includes 31 research funding organisations from the further 22 countries and 6 regions: Belgium, Canada (Quebec), Croatia, Denmark, Egypt, Finland, France, Germany (Saxony), Greece, Hungary, Ireland, Israel, Italy (Lombardy, Tuscany), Latvia, Luxembourg, Norway, Panama, Poland, Romania, Slovenia, Spain (Catalonia, Navarre) and Sweden. The available budget for this call is 24.6 Mio€ (approx.).
Scope of the call
Proposals must be interdisciplinary and clearly demonstrate the potential impact on PM as well as the added value of transnational collaboration.
The JTC2019 of ERA PerMed will comprise three Research Areas:
Each project proposal MUST address at least one module of Research Area 3 and at least one module of Research Area 1 or 2. The coherent integration and combination of the different Research Areas and Modules in the proposals will be part of the evaluation process.
Consortium composition
Joint research proposals may be submitted by applicants belonging to one of the following categories (A, B and/or C), if eligible according to relevant regional/national funding organisations’ regulations for research funding:
A. Academia or research institutes;
B. Clinical/public health sector;
C. (Industry) Private partners, e.g. SMEs (small and medium-size enterprises).
Only transnational projects will be funded. Each consortium submitting a proposal must involve at least three partners eligible for funding coming from three different countries whose funders participate in the call. All three legal entities must be independent of each other. The coordinator must be eligible to be funded by the participating funding organisations to this call. The maximum number of partners per project is six though not more than 2 eligible partners from the same country participating in the call will be accepted in one consortium (including those partners with own funding).
Research groups not eligible for funding (e.g. from non-funding countries or not fundable according to regional/national regulations of the participating funding organisation) may participate in transnational projects if they are able to secure their own funding. They are considered as full partners and have to be integrated in the pre- and full-proposal templates as such. No more than one partner with own funding is allowed in consortia with at least 3 partners that are eligible for funding.
At the full-proposal stage, a consortium might be increased up to seven partners in total only by inclusion of a partner coming from an underrepresented country. A list of underrepresented countries will be provided to coordinators invited for full-proposals submission.
The call is likely to be launched in December 2019 with a submission deadline for pre-proposals in March 2020. It is expected, that consortia invited for the full-proposal stage, will need to submit their proposal on June 15th, 2020.
The information provided in this pre-announcement is indicative and may be subject to changes and is not legally binding to funding organisations. Additional funding organisations might join the call before the official publication.
For more information: http://www.erapermed.eu/pre-announcement-jtc-2020/
